Press release
Investigation announced for Long-Term Investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) over potential Wrongdoing
An investigation on behalf of current long term investors in Neumora Therapeutics, Inc. (NASDAQ: NMRA) shares.
Investors who are current long term investors in Neumora Therapeutics, Inc. (NASDAQ: NMRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: NMRA stocks follows a lawsuit filed against Neumora Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NMRA stocks, concerns whether certain Neumora Therapeutics, Inc. officers and directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that Offering Documents that were filed in connection with Neumora's September 2023 initial public offering contained false and/or misleading statements and/or failed to disclose that in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn's original Phase Two Trial inclusion criteria to include a patient population with moderate to severe MDD to show that Navacaprant offered a statistically significant improvement in treating MDD, that and to that same end, the Company also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD, and that the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study.
Those who purchased shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Neumora Therapeutics, Inc. (NASDAQ: NMRA) over potential Wrongdoing here
News-ID: 4002139 • Views: …
More Releases from Shareholders Foundation, Inc.
Long-Term Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) shou …
An investigation was announced on behalf of current long-term investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) concerning potential breaches of fiduciary duties by certain directors of Intellia Therapeutics, Inc.
Investors who are current long term investors in Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Lawsuit filed for Investors who lost money with shares of Avis Budget Group, Inc …
An investor, who purchased shares of Avis Budget Group, Inc. (NASDAQ: CAR), filed a lawsuit over alleged violations of Federal Securities Laws by Avis Budget Group, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Avis Budget Group, Inc. (NASDAQ: CAR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2025. NASDAQ: CAR investors should contact the Shareholders…
Long-Term investors in FMC Corporation (NYSE: FMC) shares should contact the Sha …
An investigation on behalf of current long-term investors in shares of FMC Corporation (NYSE: FMC) concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation was announced.
Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Investigation announced for Long-Term Investors in shares of TransMedics Group, …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of TransMedics Group, Inc.
Investors who are current long term investors in TransMedics Group, Inc. (NASDAQ: TMDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TMDX stocks follows a lawsuit filed against TransMedics…
